Navigation Links
The American Society of Hematology announces 2012 Scholar Award winners

WASHINGTON The American Society of Hematology (ASH) announces the recipients of its 2012 Scholar Awards. The ASH Scholar Awards provide monetary support for fellows and junior faculty pursuing research careers to assist them during the critical period in which they must complete their training and achieve status as an independent investigator.

The awards, totaling $100,000 for fellows and $150,000 for junior faculty over a two- to three-year period, are made possible through grants from the corporate community, individual donors, foundations, and funds committed by the Society. The Society is proud to recognize this year's corporate supporters, which include Amgen, Celgene Corporation, Grifols USA, Novartis Oncology, Onyx Pharmaceuticals, Pfizer, and Seattle Genetics. The Society is especially grateful to Millennium: The Takeda Oncology Company for its lead support this year in the amount of $600,000.

"The ASH Scholar Awards demonstrate the Society's strong commitment to supporting hematology research despite the challenging current economic climate and threatened funding cuts to the National Institutes of Health," said ASH President J. Evan Sadler, MD, PhD, of the Washington University School of Medicine in St. Louis. "We thank our partners for their support of this program and of the next generation of hematology researchers."

The 2012 Scholar Award recipients are:

Basic Research Fellows

Yanwen Jiang, PhD
Joan & Sanford I. Weill Medical College of Cornell University

Andrew Kim, PhD
University of California, San Francisco

Amelie Montel-Hagen, PhD
The Regents of the University of California

John Anto Pulikkan, PhD
University of Massachusetts Medical School

Borja Saez, PhD
President and Fellows of Harvard College

Pamela Wenzel, PhD
Children's Hospital Boston

Anne Zaiss, PhD
University of California, Los Angeles

Clinical/Translational Research Fellows

Sophia Adamia, PhD
Dana-Farber Cancer Institute

Fabiana Perna, MD
Memorial Sloan-Kettering Cancer Center

Basic Research Junior Faculty

Rafael Bejar, MD, PhD
Brigham and Women's Hospital

Leandro Cerchietti, MD
Joan & Sanford I. Weill Medical College of Cornell University

Stella Chou, MD
The Children's Hospital of Philadelphia

Peng Ji, MD, PhD
Northwestern University

Mondira Kundu, MD, PhD
St. Jude Children's Research Hospital

Shannon McKinney-Freeman, PhD
St. Jude Children's Research Hospital

Vu Ngo, PhD
Beckmam Research Institute, City of Hope

Shunbin Ning, PhD
University of Miami

Jing Wang, MD, PhD
University of Colorado, Denver

Clinical/Translational Research Junior Faculty

James Bradner, MD
Dana-Farber Cancer Institute

Sarah Holstein, MD, PhD
University of Iowa

Jing Yang, PhD
University of Texas MD Anderson Cancer Center

Jun Yang, PhD
St. Jude Children's Research Hospital

Joanne Levy, MD Memorial Award for Outstanding Achievement

Anil K. Chauhan, PhD, Assistant Professor of Internal Medicine at the University of Iowa in Iowa City, IA, will receive the 2012 Joanne Levy, MD Memorial Award for Outstanding Achievement. This award, made possible by the family of past ASH Scholar Award recipient and distinguished Society member Joanne Levy who passed away in 2004, is given to the current ASH Scholar with the highest scoring abstract at the ASH annual meeting.

Dr. Chauhan's award will provide funding for him to continue his laboratory research focusing on the role of adhesion molecules in thrombosis and inflammation. Dr. Chauhan's laboratory currently uses intravital microscopy to study the interaction of platelets and leukocytes with the endothelium followed by stimulation or injury. Most of his work involves genetically modified mice combined with disease models such as atherosclerosis and ischemic stroke. Dr. Chauhan's most recent research focuses on investigating the role of EDA-containing fibronectin in ischemic stroke.

Dr. Chauhan received his PhD from the International Centre for Biotechnology and Genetic Engineering in Trieste, Italy, and he completed his postdoctoral training in the field of thrombosis and hemostasis at the Immune Disease Institute and Harvard Medical School in Boston.


The American Society of Hematology is the world's largest professional society concerned with the causes and treatment of blood disorders. Its mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting blood, bone marrow, and the immunologic, hemostatic, and vascular systems by promoting research, clinical care, education, training, and advocacy in hematology. The official journal of ASH is Blood, the most cited peer-reviewed publication in the field, which is available weekly in print and online.

Contact: Lindsey Love
American Society of Hematology

Related medicine news :

1. American Council on Exercise (ACE) Study Reveals Kettlebells Provide Powerful Workout in Short Amount of Time
2. Satellite Healthcares Sheila Doss Elected Western Chapters Coordinator-Elect of the American Nephrology Nurses Association
3. Luth Researchs IndicatorEDG(TM) Study Finds Americans Hopes of Achieving Their Dreams Are Fading
4. Highmark Foundation Awards $120,000 to the American Heart Association
5. American Heart Association Rapid Access Journal Report: Study Finds Racial Gaps Continue in Heart Disease Awareness, Low Knowledge of Heart Attack Warning Signs Among Women
6. New American Heart Association Survey Finds Heart Disease and Stroke Patients Face Significant Barriers in Obtaining Quality, Affordable Care
7. American Heart Association Comment on Hospitalization of President Bill Clinton
8. Majority of Americans Approve of President Obamas Handling of Afghanistan and National Security But Disapprove of Handling of Economic Issues, Per Franklin & Marshall College Poll With Hearst Television
9. American Red Cross Issues One-Month Progress Report for Haiti Earthquake
10. 57 Million Americans Sickened by H1N1 Flu: CDC
11. Concentra, American Showa to Open Associates Health Center in Blanchester, Ohio
Post Your Comments:
(Date:11/26/2015)... ... November 26, 2015 , ... WorldCare International, Inc., ... the 61st annual Employee Benefits Conference. The Employee Benefits Conference was hosted by ... through Wednesday, November 11th, 2015. The conference was held at the Hawaii Convention ...
(Date:11/26/2015)... ... November 26, 2015 , ... Indosoft Inc., developer and distributor of ... server to improve system efficiency and reliability. , The new Q-Suite 6 platform is ... the system avoids locking itself into a specific piece of software for many key ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... preparing the perfect dish and pleasing the palates of attendees is of the ... a dish to a seasonal get-together, give these recipes a try this holiday ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... offering factory direct sauna parts and accessories. , Sauna accessories help improve the ... bather’s style and personality. From basic styles for the purist looking for simplicity ...
(Date:11/25/2015)... ... ... On November 10, 2015, Bohrer Brady, LLC filed a class and collective ... home health care worker who provided companionship services for the elderly, ill or disabled ... Humana, Inc., Humana at Home, Inc., and SeniorBridge Family Companies (CT), Inc. since January ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... 2015  Amgen (NASDAQ: AMGN ) today announced ... the United States (U.S.) Food ... candidate to Humira ® (adalimumab). Amgen believes this ... the FDA and represents Amgen,s first BLA submission using ... , M.D., executive vice president of Research and Development ...
(Date:11/25/2015)... -- On Tuesday, November 24, 2015, the jury ... Medical Technology, Inc. for product liability and misrepresentation ... device, awarded $11 million in favor of Plaintiff ... three days of deliberations, the jury found that ... and unreasonably dangerous, and that Wright Medical made ...
(Date:11/25/2015)... Nov. 25, 2015 Allergan plc (NYSE: AGN ... the New York State Attorney General,s ... Sherman Act, and other statutes with the Attorney General over ... to cease marketing and selling the now generic version of ... admits no liability, has released its counterclaims against ...
Breaking Medicine Technology: